Zawada, Adam M
Wolf, Melanie
Rincon Bello, Abraham
Ramos-Sanchez, Rosa
Hurtado Munoz, Sara
Ribera Tello, Laura
Mora-Macia, Josep
Fernández-Robres, M. Amparo
Soler-Garcia, Jordi
Aguilera Jover, Josep
Moreso, Francesc
Stuard, Stefano
Stauss-Grabo, Manuela
Winter, Anke
Canaud, Bernard
Article History
Received: 12 August 2022
Accepted: 20 January 2023
First Online: 15 February 2023
Declarations
:
: All patients gave written informed consent to participate in the clinical study and the study was approved by the ethics committee (Comité Ético de Investigación Clínica del Hospital Clínic de Barcelona, code: HD-T50-01-ES). The study was performed in adherence with the Declaration of Helsinki. The study is registered at clinicaltrials.gov (NCT03292029, registration on 25/09/2017).
: Not applicable. Data was used in aggregate with no personal identifiers.
: During study design implementation and completion all authors were employees of Fresenius Medical Care and/or NephroCare Spain and may hold stock in the company.